期刊文献+

Toll样受体与冠心病 被引量:1

Toll-like receptor in coronary atherosclerotic heart disease
下载PDF
导出
摘要 冠心病是一种慢性炎症性免疫性疾病,冠心病的各种危险因素通过对Toll样受体家族基因和其下游炎症网络的调控,参与冠心病的炎症和免疫反应。炎症和免疫反应损伤血管,引起脂质浸润,平滑肌细胞增殖,导致斑块形成,炎症免疫反应又可以促进斑块的发展。Toll样受体介导冠状动脉粥样斑块的发生、进展、斑块不稳定乃至破裂等。干预Toll样受体家族,可能是冠状动脉粥样硬化性心脏病防治的新靶点。 Coronary atherosclerotie heart disease (CHD) is a chronic inflammatory and autoimmune disease. Various risk factors of CHD involved in the infflammatory and immune responses through regulated toll-like receptor genes and its downstream inflammatory network. Inflammation and immune responses of CHD injury vascular,cause lipid infiltration and smooth muscle cell proliferation, which will result in coronary arterial plaque formation. Moreover, inflammatory and immune response of CHD can promote the development of plaques. Toll-like receptors mediated coronary atherosclerosis progress and plaque rupture. To intervene toll-like receptor family, may be a new target for CHD prevention and therapy.
出处 《国际内科学杂志》 CAS 2007年第10期571-573,共3页 International Journal of Internal Medicine
关键词 TOLL样受体 冠心病 病理生理 Toll like receptor Coronary atherosclerotic heart disease Pathophysiological
  • 相关文献

参考文献24

  • 1Nilsson J, Fredrikson GN. Atherosclerosis. Autoimmunity, 2004,37(4) :351-355.
  • 2Takeda K, Kaisho T, Akira S. Toll-like receptors. Annu Rev Immunol,2003,21:335-376.
  • 3Cook DN, Pisetsky DS, Schwartz DA, et al. Toll-like receptors in the pathogenesis of human disease. Nat Immunol,2004,5 (10) :975-979.
  • 4Edfeldt K, Swedenborg J, Hansson GK, et al. Expression of toll-like receptors in human atherosclerotic lesions:A possible pathway for plaque activation. Circulation, 2002, 105(10) :1158-1161.
  • 5Bjorkbacka H, Kunjathoor VV, Moore KJ,et al. Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways. Nat Med,2004,10:416-421.
  • 6Xu XH, Shah PK,Faure E ,et al. Toll like receptor 2,4 is expressed in murine and human lip id-rich atherosclerotic plaques and up regulated by oxidized LDL. Circulation, 2001,104:3103-3108.
  • 7Miller YI, Viriyakosol S, Binder C J, et al. Minimally modified LDL binds to CD14, induces macrophage spreading via TLR4/MD22, and inhibits phagocytosis of apoptotic cells. J Biol Chem,2003,278 : 1561-1568.
  • 8Miller YI, Chang MK, Binder CJ, et al. Oxidized low-density lipoprotein and innate immune receptors. Curr Opin Lipidol, 2003,14:4372-4451.
  • 9Bochkov VN, Kadl A, Huber J, et al. Protective role of phospholipid oxidation products in endotoxin-induced tissue damage. Nature ,2002,419:772-811.
  • 10Dunzendorfer S, Lee KH, Tobias PS, et al. Flow-dependent regulation of endothelial toll-like receptor 2 expression through inhibition of SP1 activity. Circ Res, 2004,95 ( 7 ) : 684-691.

同被引文献3

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部